Browsing Department of Biomedicine by Subject "Bevacizumab"
Now showing items 1-1 of 1
(Springer, 2014-10-17)Anti-angiogenic therapy in glioblastoma (GBM) has unfortunately not led to the anticipated improvement in patient prognosis. We here describe how human GBM adapts to bevacizumab treatment at the metabolic level. By performing ...Journal article